New York 2025 Session Status: Introduced

S9279 — Relates to the operation of gene synthesis providers and manufacturers of gene synthesis equipment

Last action — Senate Floor Calendar

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed Assembly
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the Senate. Introduced February 24, 2026. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

Regulates gene synthesis providers and manufacturers of gene synthesis equipment.

This bill requires gene synthesis providers and manufacturers to follow health department rules, including identifying dangerous sequences and keeping records. The full text of the bill is not available.

Summary

Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.

Bill Text

Action History

  1. SUBSTITUTED BY A3283C

  2. ADVANCED TO THIRD READING

  3. 2ND REPORT CAL.

  4. 1ST REPORT CAL.1239

  5. PRINT NUMBER 9279A

  6. AMEND AND RECOMMIT TO HEALTH

  7. REFERRED TO HEALTH

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 218 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (218)

218 members have not signed on to this bill.

Show all 218 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare technology
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does S9279 do?
Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.
Who sponsors S9279?
S9279 is sponsored by Michael Gianaris.
What is the current status of S9279?
This bill has been introduced in the Senate. Introduced February 24, 2026. It must pass committee before a floor vote.
Where can I track S9279?
Track S9279 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S9279

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of S9279

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →